Medications

FDA approves exagamglogene autotemcel to treat beta-thalassemia

After approving Casgevy (exagamglogene autotemcel) in December to treat sickle cell disease, the U.S. Food and Drug Administration announced Tuesday that the therapy has now been approved to treat patients older than 12 years ...

Diseases, Conditions, Syndromes

Sickle cell raises COVID-19 risk, but vaccination lags: Study

Despite the fact that people with sickle cell disease have a much higher risk of serious illness or death if they develop COVID-19, a new study shows they're also much less likely than those without sickle cell disease to ...

page 2 from 36